Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Exozymes Inc's Competitiveness

Name: Exozymes Inc Competitors and Peer Comparison
Creator: CSIMarket
License: https://csimarket.com/help/terms-of-use

A competitive positioning analysis and financial ratio benchmarking of Exozymes Inc (EXOZ) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2026

API endpoints for this dataset

                        https://api.csimarket.com/api/v1/companies/EXOZ/competitors                    

                        https://api.csimarket.com/api/v1/companies/EXOZ/relationships                    

                        https://api.csimarket.com/api/v1/companies/EXOZ/similar                    

Programmatic access for models, analytics, and integration workflows.

Pull these exact ratios programmatically

Get an API key License this feed for redistribution / AI →

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AI Integration via MCP

Connect Claude, ChatGPT, or any MCP-compatible AI assistant directly to this data.

Exozymes Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity	Profitable	Expanding	Above Industry Growth	Distressed
Exozymes Inc	-	-	-	Yes
High-Confidence Competitors (2)
Similar-Size Competitors (10)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

EXOZ Stock Performance relative to its Competitors

EXOZ Competitors (weighted) Percent change over the selected range

Exozymes Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.

High-Confidence
(1 of 2)

Similar-Size
(1 of 10)

Entity	TTM Share Price Return (group: median)	vs U.S.A. 500
Exozymes Inc	-	-
Competitors combined (0)	40.4%	63.2%
High-Confidence Competitors (2)	40.4%	63.2%
Similar-Size Competitors (10)	40.4%	63.2%
Similar Growth & Profitability (0)	40.4%	63.2%

Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Exozymes Inc's competitor groups requires a Commercial License.

Unlock Commercial Access

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

EXOZ Stock Performance relative to High-Confidence Competitors

EXOZ High-Confidence Competitors (equal-weighted, 2) Percent change over the selected range

EXOZ Stock Performance relative to Similar-Size Competitors

EXOZ Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

Exozymes Inc's Comment on Competition and Industry Peers

eXoZymes operates in a competitive global market alongside established companies specializing in products derived from synthetic chemistry or natural extraction. These competitors often possess greater financial resources, brand recognition, scientific reputation, and industry connections, and many are multinational, publicly listed companies with large market capitalizations. eXoZymes differentiates itself through its founder's reputation, strategic partnerships, experienced management and staff, and proprietary technologies. Its intellectual property portfolio includes trade secrets and specialized methods, such as recycling essential cofactors, which provide advantages over traditional synthetic biochemical companies. In the biofuels sector, eXoZymes focuses on isobutanol production and does not compete directly with ethanol producers.

Competitor data is not yet available for Exozymes Inc.

Exozymes Inc's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.

Competitor	Basis	Confidence	Active	Sources
ADM Corporation	Named by the company	85%	2022 to 2026	3
Gevo, Inc.	Named by the company	85%	2022 to 2026	3
Butamax Advanced Biofuels LLC	Named by the company	85%	2022 to 2026	3
Cargill Company	Named by the company	85%	2022 to 2026	3

Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Exozymes Inc's named competitors require a Commercial License.

Unlock Commercial Access

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.